Alkermes
ALKS
#2921
Rank
NZ$9.41 B
Marketcap
NZ$57.02
Share price
-1.40%
Change (1 day)
4.30%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2025 (TTM): NZ$0.70 Billion

According to Alkermes's latest financial reports the company's current earnings are NZ$1.52 Billion. In 2024 the company made an earning of NZ$0.77 Billion a decrease over its 2023 earnings that were of NZ$0.94 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.70 B-9.21%
2024 NZ$0.77 B-17.97%
2023 NZ$0.94 B-468.52%
2022 -NZ$0.26 Billion449.24%
2021 -NZ$46.46 Million-68.04%
2020 -NZ$0.15 Billion-52.1%
2019 -NZ$0.31 Billion64.49%
2018 -NZ$0.19 Billion-15.04%
2017 -NZ$0.22 Billion-34.2%
2016 -NZ$0.33 Billion-5.34%
2015 -NZ$0.35 Billion35084.97%
2014 -NZ$1 Million
2012 NZ$12.27 M-117.81%
2011 -NZ$68.95 Million-12.69%
2010 -NZ$78.97 Million94.3%
2009 -NZ$40.65 Million-117.7%
2008 NZ$0.22 B622.63%
2007 NZ$31.77 M
2004 -NZ$0.13 Billion-14.48%
2003 -NZ$0.15 Billion11.88%
2002 -NZ$0.14 Billion39.65%
2001 -NZ$94.06 Million5.73%
2000 -NZ$88.96 Million-28.91%
1999 -NZ$0.13 Billion237.28%
1998 -NZ$37.1 Million100.05%
1997 -NZ$18.55 Million-37.93%
1996 -NZ$29.88 Million82.72%
1995 -NZ$16.35 Million-26.79%
1994 -NZ$22.34 Million-72.78%
1993 -NZ$82.05 Million208.07%
1992 -NZ$26.64 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$53.58 B 7,886.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.15 B 3,947.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$19.60 B 2,822.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$15.05 B 2,143.60%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$13.28 B 1,880.47%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$21.65 B 3,127.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-NZ$0.36 Billion-152.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-NZ$0.45 Billion-167.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.93 B 336.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel